Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Mulcahy

Phoenix, AZ Medical Doctor

NPI 1255327193 CMS profile 147961

202 E Earll Dr, Ste. 360, Phoenix, AZ 85012

Open in the dashboard

General payments

$840,588

743 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Mulcahy of Phoenix, AZ is reported in the CMS Open Payments database as having received $840,588 across 743 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64,213 57
2024 General $69,901 71
2023 General $139,853 140
2022 General $173,429 165
2021 General $118,158 102
2020 General $44,496 31
2019 General $230,538 177

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Mulcahy
  • Arizona median
  • Middle half of Arizona
  • National median

In program year 2025, general payments to John Mulcahy were reported at $64,213. Among 22,468 Arizona profiles paid that year, the median was $185 and the middle half received between $57 and $677.

Show as a table
Year John Mulcahy Arizona median Middle half National median
2019 $230,538 $185 $53–$752 $163
2020 $44,496 $124 $36–$453 $114
2021 $118,158 $153 $43–$556 $132
2022 $173,429 $174 $50–$618 $149
2023 $139,853 $182 $55–$645 $160
2024 $69,901 $184 $56–$660 $164
2025 $64,213 $185 $57–$677 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $756,911 646 payments
  2. Coloplast Corp $83,627 96 payments
  3. Antares Pharma, Inc. $50 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $672,723 262 payments
  2. Travel and Lodging $81,883 217 payments
  3. Education $48,624 39 payments
  4. Food and Beverage $22,432 206 payments
  5. Consulting Fee $14,926 19 payments
Products named General payments · program years 2019–2025
  1. AMS 700 CXR RTE Kit AMS 700 CXR RTE Kit_URO $253,381 190 payments
  2. CROSSBOSS $167,302 80 payments
  3. TACTRA $91,495 75 payments
  4. AMS 700 CXR RTE KIT Pain Management $77,423 38 payments
  5. AMS $77,295 69 payments
  6. Titan Men's Health $62,378 70 payments
  7. AMS Ambicor $35,726 40 payments
  8. TITAN Penile Reconstruction $21,069 24 payments
  9. General - Male SUI $16,207 6 payments
  10. GENERAL THERAPIES $8,362 17 payments
  11. Other $21,317 106 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

743 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record